ImmunoTek Bio Centers
ImmunoTek Bio Centers operates the world's largest independent network of US plasma donation centers, collecting source plasma from compensated donors and supplying it to biopharmaceutical manufacturers for fractionation into plasma-derived therapies.
- Company typePrivate
- Founded2013
- HeadquartersSouthlake, United States
- Headcount251–500
- GTM typeB2B and B2C
- OfferingServices
What ImmunoTek Bio Centers does
ImmunoTek Bio Centers, LLC is a privately held US biotech operating company founded on July 18, 2013 by Jerome Parnell III and headquartered in Southlake, Texas. It is the self-described world's largest and fastest-growing independent blood plasma collection company, operating approximately 45 plasma donation centers across 21 states through two sub-brands: the wholly-owned ImmunoTek Plasma network and the co-developed Freedom Plasma network, which it operates in partnership with a global healthcare company and leading manufacturer of plasma-derived medicines. Across its first decade, the company has accepted more than 7 million paid donations and developed more than 80 centers for biopharmaceutical partners.
The company's core service is automated plasmapheresis — a sterile, single-use process that separates plasma from whole blood and returns remaining components to the donor, allowing donations up to twice per week. Donor screening is supported by Haemonetics-powered biometric fingerprint authentication that produces a numerical electronic signature stored in the donor profile, and needle insertion is aided by Christie Medical Holdings' VeinViewer real-time vein illumination technology, in which ImmunoTek is the first plasma collection operator to deploy. Donors are compensated via a prepaid debit card, and the iTek Referral Network pays $50 per successfully referred second-time donor.
ImmunoTek's commercial model is hybrid B2B/B2C. On the supply side, it acquires raw material (plasma) from a long tail of individual donors compensated per donation. On the demand side, it sells that plasma to biopharmaceutical manufacturers under supply agreements for fractionation into plasma-derived therapies (immunoglobulins, clotting factors, albumin, alpha-1 antitrypsin) used in immune deficiencies, bleeding disorders, burns, trauma, and rare diseases. Revenue mechanics are transactional per liter of plasma supplied. Most centers hold or are pursuing US FDA licensure and European certification, and the CEO sits on the PPTA Global Source Board of Directors, giving the firm meaningful influence over industry sourcing standards.
ImmunoTek Bio Centers firmographics
Firmographics- Name
- ImmunoTek Bio Centers
- Legal name
- ImmunoTek Bio Centers, LLC
- Website
- https://immunotek.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- ImmunoTek Bio Centers operates the world's largest independent network of US plasma donation centers, collecting source plasma from compensated donors and supplying it to biopharmaceutical manufacturers for fractionation into plasma-derived therapies.
- Ownership category
- akta.pro rank
ImmunoTek Bio Centers industry classification
Industry- Product category
- Plasma Collection Services
- NAICS
- Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414), Medical Laboratories (621511)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
- akta.pro secondary industries
- Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Immunoglobulins & Passive Immunization Biologics (IVIG, hyperimmune globulins, antitoxins) (HLAAAEAH)
Keywords
Where ImmunoTek Bio Centers is headquartered
LocationHeadquarters
- HQ city
- Southlake
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ImmunoTek Bio Centers business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D
Revenue model
- Plasma Collection Services: ImmunoTek collects plasma from paid donors at its collection centers and supplies the plasma to biopharmaceutical companies for manufacturing plasma-based therapies. The company generates revenue through payments from biotech partners for plasma supply.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Variable donor compensation based on center location |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
ImmunoTek Bio Centers product offering
Product offeringCore offering
ImmunoTek Bio Centers operates a nationwide network of FDA-licensed plasma donation centers under two brands, ImmunoTek Plasma and Freedom Plasma. It collects source plasma from compensated individual donors via automated plasmapheresis and supplies that plasma to biopharmaceutical manufacturers for use in plasma-derived therapies. Donors are screened, identified via biometric fingerprint authentication, and compensated through a pre-paid debit card.
Product overview
ImmunoTek Bio Centers operates a network of plasma donation centers under two sub-brands: ImmunoTek Plasma (the primary brand) and Freedom Plasma (operated in partnership with a global healthcare company). The company's core service is plasmapheresis collection — a sterile, automated process that separates plasma from donor blood and returns remaining components. Donors are compensated via a pre-paid debit card. Supporting programs include a referral network that rewards donors $50 per successful referral, and biometric donor identification using fingerprint scanning technology powered by Haemonetics. The company celebrated its 10th anniversary in July 2023 and operates approximately 45 centers across 21 states through its two subsidiaries.
Differentiator
Problem solved
Functional benefit
Products and services
- Plasmapheresis Collection Services Automated, sterile, self-contained plasmapheresis process that separates plasma from donor whole blood and returns the remaining components to the donor, performed at ImmunoTek and Freedom Plasma donation centers across the United States for healthy adult donors aged 18-65.
- ImmunoTek Plasma Center Operations Company-owned plasma donation centers operating under the ImmunoTek Plasma brand, providing donor screening, plasmapheresis collection, and donor compensation across multiple U.S. states.
- Freedom Plasma Center Operations Plasma donation centers operated by ImmunoTek in partnership with a global healthcare company and plasma-derived-medicine manufacturer, compensating donors and contributing to the global plasma supply chain.
- B2B Plasma Supply to Biopharmaceutical Manufacturers Long-term supply of FDA-licensed source plasma collected at ImmunoTek and Freedom Plasma centers to global biopharmaceutical companies for manufacturing plasma-based therapies treating rare diseases, immune deficiencies, bleeding disorders, burns, surgical trauma, and shock.
- VeinViewer-Assisted Donor Experience Plasmapheresis collection enhanced by Christie Medical Holdings' VeinViewer direct-projection vein illumination, which displays real-time images of donor veins on the skin before needle insertion to increase accuracy and reduce reinsertions.
Quantifiable outcome
- More than 7 million paid donations accepted since 2013
- +3 more outcomes
Companies that use ImmunoTek Bio Centers
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
ImmunoTek Bio Centers technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
ImmunoTek Bio Centers partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- Plasma Protein Therapeutics Association (PPTA)minorJerome Parnell III, CEO and President of ImmunoTek Bio Centers, was elected to serve on the PPTA Global Source Board of Directors. PPTA represents blood-plasma collection centers and manufacturers of lifesaving protein therapies made from plasma, working to support access and affordability of plasma-based therapies.
- Global Healthcare Company (Freedom Plasma Partner)coreFreedom Plasma was developed and is managed by ImmunoTek Bio Centers in partnership with a global healthcare company and leading manufacturer of plasma-derived medicines. This partnership enables Freedom Plasma to offer donors compensation while contributing to the global plasma supply chain.
- Haemonetics CorporationcoreImmunoTek uses Haemonetics software and database service for fingerprint scan donor authentication as part of the automated plasmapheresis program and donor screening process. The finger scanner biometric data is stored in Haemonetics' database as part of the software service.
Scale indicators9 records
Recent moves9 records
Expansion highlights6 records
ImmunoTek Bio Centers competitors and assessment
Company assessmentDirect peers
- CSL Plasma: CSL Plasma is the plasma collection arm of CSL Behring and operates one of the largest global networks of plasma collection centers. It is the most directly comparable peer to ImmunoTek — both operate paid donor centers in the U.S. and supply source plasma to biopharmaceutical manufacturers for fractionation into plasma-derived therapies.
- Grifols: Grifols is a vertically integrated global biopharmaceutical company that operates its own plasma collection network (including acquired centers from Biotest and others) and fractionates plasma into therapies. It directly competes with ImmunoTek in U.S. plasma collection and is also one of ImmunoTek's potential B2B buyers.
- BioLife Plasma Services: BioLife Plasma Services is the U.S. plasma collection subsidiary of Takeda Pharmaceutical Company, operating hundreds of paid donor centers across the U.S. Like ImmunoTek, it supplies source plasma to its parent for fractionation, but operates as an integrated player with greater capital backing and a comparable donor experience model.
- Octapharma Plasma: Octapharma Plasma operates more than 150 donation centers across the U.S. and is part of Octapharma AG, a global manufacturer of plasma-derived medicines. It competes directly with ImmunoTek for paid donors and represents both a comparable operator and a potential B2B customer relationship.
- Kedrion Biopharma: Kedrion is an Italy-headquartered biopharmaceutical company that collects plasma and manufactures plasma-derived therapies, with growing U.S. collection operations. It is comparable to ImmunoTek as a plasma collector and a potential strategic partner for center development.
- BPL Plasma: BPL Plasma operates a network of plasma donation centers across the U.S. and is associated with Bio Products Laboratory, a manufacturer of plasma-derived therapies. It directly competes with ImmunoTek for paid donors in overlapping U.S. geographies.
Broad incumbents
- ADMA Biologics: ADMA Biologics is a U.S. biopharmaceutical company that manufactures plasma-derived therapies and is expanding its own vertical supply chain. While not a center operator at ImmunoTek's scale, it is a relevant comparable as a U.S.-based plasma end-buyer and increasingly integrated competitor.
- Takeda Pharmaceutical Company: Takeda owns BioLife Plasma Services, the parent of ImmunoTek's largest direct competitor, and is a major global buyer and fractionator of plasma. It is comparable as a vertically integrated incumbent shaping competitive dynamics and contract pricing in the U.S. source plasma market.
Regional players
- Sanquin Plasma Products: Sanquin is the Dutch national blood and plasma collection organization, operating plasma collection centers primarily in the Netherlands and Europe. It is comparable to ImmunoTek in operating paid/unpaid donor collection networks and supplying plasma to fractionators, but in a different geography and nonprofit structure.
Others
- Haemonetics Corporation: Haemonetics is a medical technology company that supplies plasmapheresis equipment and software (including the biometric donor authentication system used by ImmunoTek). It is comparable as an enabling technology partner in the plasma collection value chain rather than a direct competitor.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key highlights7 records
Customer concentration
ImmunoTek Bio Centers social profiles
Digital presenceImmunoTek Bio Centers financial estimates
Financial estimateRevenue estimate
Valuation estimate
ImmunoTek Bio Centers leadership team
Management profileNumber of profiles
Profiles3 records
ImmunoTek Bio Centers subsidiaries and ownership
Company hierarchySubsidiaries2 records
ImmunoTek Bio Centers funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ImmunoTek Bio Centers M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ImmunoTek Bio Centers
What does ImmunoTek Bio Centers do?
ImmunoTek Bio Centers operates a nationwide network of FDA-licensed plasma donation centers under two brands, ImmunoTek Plasma and Freedom Plasma. It collects source plasma from compensated individual donors via automated plasmapheresis and supplies that plasma to biopharmaceutical manufacturers for use in plasma-derived therapies. Donors are screened, identified via biometric fingerprint authentication, and compensated through a pre-paid debit card.
Is ImmunoTek Bio Centers a public or private company?
ImmunoTek Bio Centers is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ImmunoTek Bio Centers founded?
ImmunoTek Bio Centers was founded in 2013. It employs 251 to 500 people.
Where is ImmunoTek Bio Centers based?
ImmunoTek Bio Centers is headquartered in Southlake, United States, in the North America region.
How does ImmunoTek Bio Centers make money?
One revenue line is on record: plasma Collection Services.
Who are ImmunoTek Bio Centers's main competitors?
Direct peers on record are CSL Plasma, Grifols, BioLife Plasma Services, Octapharma Plasma, Kedrion Biopharma and BPL Plasma. Broad incumbents are ADMA Biologics and Takeda Pharmaceutical Company. Sanquin Plasma Products is listed as a regional player. Haemonetics Corporation is listed as an others.
Does ImmunoTek Bio Centers have an API?
No public API is recorded for ImmunoTek Bio Centers.
What industry is ImmunoTek Bio Centers in?
ImmunoTek Bio Centers's product category is Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of HLAFAMAG, Transfusion Medicine & Immunohematology (Blood Bank). Its NAICS code is 621991 and its SIC code is 2836.